for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
The Tan Sheet  
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [13 journals]
  • Alka-Seltzer ‘Apples-To-Oranges’
           Comparison With NyQuil Smells Rotten To NAD
    • Abstract: Bayer discontinues an ad comparing Alka-Seltzer Plus Night Cold & Flu, which is indicated for nasal decongestion, with P&G's NyQuil Cold & Flu, which is not. The review centered on NAD's “apples to oranges” principle that marketers should not mislead on the similarities of competing formulas.
      PubDate: Fri, 23 Jan 2015 00:00:03 -050
  • Clean Bill Of Health For BPA In Europe As FDA Examination Continues
    • Abstract: EFSA’s conclusion tracks Canadian authorities’ 2009 finding but differs from the U.S. 2013 decision banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.
      PubDate: Thu, 22 Jan 2015 00:05:00 -050
  • Industry Roundup: P&G Executive Moves; Warnings On Spiked
           Products, Supplement-Beverage Divide; and FTC OKs GSK/Novartis JV
    • Abstract: David Taylor adds group president for global beauty to his responsibilities and former beauty group head Deb Henretta leads the firm’s online business group. FTC members unanimously sign off on the agency staff’s proposal to approve Novartis’ consumer health care products joint venture with Glaxo.
      PubDate: Thu, 22 Jan 2015 00:00:03 -050
  • J&J Includes Listerine In 20 Consumer Product
           Launches Planned In 2015
    • Abstract: CEO Alex Gorsky says “20 key product launches” are planned for 2015, including extensions for the Listerine Healthy White mouthwash Neutrogena Hydro Boost skin care lines. Analgesics and upper respiratory products drive global OTC sales growth in the fourth quarter.
      PubDate: Wed, 21 Jan 2015 00:00:02 -050
  • Weekly Trademark Review Jan. 13, 2015
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 19 Jan 2015 00:05:03 -050
  • Consumer Health Care New Products Roundup
    • Abstract: Liporidex extends with powders; Galderma enters acne category; Vinia ‘biofood’ delivers resveratrol; and NeuEnergy beverage launches.
      PubDate: Mon, 19 Jan 2015 00:01:14 -050
  • Energy Drinks In Canada Pump Up Vitamins But Exaggerate Benefits
    • Abstract: Consumer confusion over the products’ nutrient benefits might not be cleared up despite Canada’s regulatory re-categorization in 2014. Researchers found on-package labels and marketing highlighted nutritional attributes such as immune support and antioxidant properties.
      PubDate: Mon, 19 Jan 2015 00:01:04 -050
  • Glaxo-Novartis JV ‘On Track’ To Launch; J&J
           ‘Well Through’ Most Of OTC Remediation
    • Abstract: Glaxo’s consumer product sales will be around 25% of the $40 billion total annual revenues the firm projects following the closure of its Novartis agreement. J&J CEO Alex Gorsky sees light at the end of the tunnel for remediation of the firm’s OTC manufacturing under a consent decree with FDA.
      PubDate: Mon, 19 Jan 2015 00:00:57 -050
  • Unfettered OTC Purchasing With Pre-Tax Savings Tops CHPA Goals In 2015
    • Abstract: CHPA is optimistic 2015 is the year “common sense” will restore OTC eligibility for health spending accounts. Speaking on the group’s priorities, President and CEO Scott Melville said CHPA will work to improve the OTC monograph system and to curb cough medicine abuse.
      PubDate: Mon, 19 Jan 2015 00:00:49 -050
  • FDA Pharmaceutical Quality ‘Super Office’ Launches With
           Integrated Reviews
    • Abstract: CDER’s ‘super office’ aims to transform how industry thinks about manufacturing, but still needs to hire management and other staff.
      PubDate: Mon, 19 Jan 2015 00:00:15 -050
  • Show Me The Money: Salaries, Red Tape Challenge FDA Recruiting
    • Abstract: FDA’s drug center continues to operate with a staffing shortage at a time of tremendous pressure to implement new authorities. Janet Woodcock is left scrambling to find senior managers to lead top initiatives.
      PubDate: Mon, 19 Jan 2015 00:00:00 -050
  • CVS Supplement Deceptively Capitalizes On Proximity To AREDS-Formula
           Product – Complaint
    • Abstract: CVS supplement Advanced Eye Health deceives consumers by piggy-backing off NIH study findings of a Bausch + Lomb formula found to reduce eye disease progression, says a complaint seeking class action status in California state court.
      PubDate: Fri, 16 Jan 2015 00:05:00 -050
  • Dietary Supplement GMP Warning Letters
    • Abstract: Nutri Spec Inc. is warned about GMP problems at two of its facilities, and Engineering Nutrition Inc. fails to satisfy FDA with its response.
      PubDate: Fri, 16 Jan 2015 00:00:06 -050
  • Supplement GMP Violations Stop Mexican Firm’s Herbal Imports
    • Abstract: U.S. supplement manufacturers and marketers generally continue distributing products after FDA notes GMP problems at their facilities, but Herbolaris Internacional is not reaching customers in the U.S. since the agency posted an import alert on its products in December.
      PubDate: Thu, 15 Jan 2015 00:05:08 -050
  • In California, J&J Will Cut ‘Slack’ From Packages To
           Settle Litigation
    • Abstract: J&J consumer health and personal care product companies repackage products across their portfolio to remove excess packaging that district attorneys in California argued deceive consumers. In a stipulated final judgment, a state judge also requires J&J to pay a $506,000.
      PubDate: Thu, 15 Jan 2015 00:05:01 -050
  • NHANES Shows Supplements Curb ‘Global Nutrition Issue’ With
    • Abstract: Pharmavite-funded analysis of 2001-2008 NHANES data shows lower micronutrient intakes and higher prevalence of micronutrient inadequacy among obese adults, and that supplement usage tracks with strong micronutrient intake.
      PubDate: Wed, 14 Jan 2015 00:05:00 -050
  • Perrigo Fills 'Moat' To Protect Growth With Gummy Vitamins, European
    • Abstract: The private labeler announces Ferrara Candy will manufacture store brand gummy vitamins and supplements that Perrigo will provide to U.S. retailers. The firm expects by the end of the current quarter to close its acquisition of Belgian OTC and nutritional product manufacturer Omega Pharma.
      PubDate: Tue, 13 Jan 2015 00:05:01 -050
  • Industry News Roundup
    • Abstract: Gorsky positive on J&J’s OTC future; Galderma enters acne category; CRN Foundation extends NAD support; AHPA seeks candidates, appoints VP; and more news in brief.
      PubDate: Tue, 13 Jan 2015 00:00:02 -050
  • Fewer Proprietary Drug Names Rejected With FDA, Industry On Same Page
    • Abstract: After several false starts, FDA and the pharma industry appear to be on the same page about vetting potential brand names for new drugs. FDA’s rate of rejecting proposed brand names has dropped from 50% or higher when the decade began to about 25%, according to Office of Surveillance and Epidemiology data.
      PubDate: Mon, 12 Jan 2015 00:03:42 -050
  • FDA Recalls For Dec. 24, 2014, And Jan. 7, 2015
    • Abstract: Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
      PubDate: Mon, 12 Jan 2015 00:03:00 -050
  • Weekly Trademark Review Jan. 6, 2015
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 12 Jan 2015 00:02:21 -050
  • Pharma M&A Passed $200B In 2014, Primed For More In 2015
    • Abstract: The pharma industry in 2014 products its biggest M&A year in recent history, though it may be remembered equally for sagas and upsets that failed to materialize into finalized deals. Actavis was the most aggressive acquirer, buying Forest and Allergan for a total of $89.3 billion in the two most expensive deals of the year.
      PubDate: Mon, 12 Jan 2015 00:01:54 -050
  • International Roundup
    • Abstract: Merck targets Turkish consumer growth; delegations urge EC to study microbeads; and Japan forms R&D office, lowers tax rate.
      PubDate: Mon, 12 Jan 2015 00:01:14 -050
  • Viviscal Support Too Thin For ‘Thicker
           Hair’ Claim
    • Abstract: Claims implying specificity also imply support from clinical studies, NAD says in review of advertise ng for Lifes2good’s hair growth supplement.
      PubDate: Mon, 12 Jan 2015 00:01:07 -050
  • FDA Targets Boosting Adverse Event Review ‘Accuracy And
    • Abstract: The agency seeks academic institutions and commercial organizations with tools to triage and review post-marketing adverse event drug product case reports submitted to the Adverse Event Reporting System.
      PubDate: Mon, 12 Jan 2015 00:00:54 -050
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014